These data suggest that the inhibition of NOTCH1 results in convincing anti-leukemic effects via the reduction in proliferation and viability, induction of cell cycle arrest, and, finally, apoptosis in MLL-fusion-protein-driven leukemia, with significantly less impact on control cells. The gene discussed is KMT2A; the disease is leukemia.